Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00942877
Title Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

alveolar soft part sarcoma

Therapies

Cediranib

Age Groups: child
Covered Countries USA


No variant requirements are available.